GTHP Financials 07/16/2014 07:58:38
Guided Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,179 3,410 3,622 3,364
Cost of Revenue 611 117 106 -
Gross Profit 568 3,293 3,516 3,364
Operating Expenses
Research and Development 2,742 3,227 2,779 1,805
Sales, General and Admin. 4,434 4,347 7,493 3,180
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,606) (4,281) (6,756) (1,621)
Income From Continuing Operations
Add'l Income/Expense Items (564) - 192 2
Earnings Before Interest and Tax (7,170) (4,281) (6,564) (1,619)
Interest Expense 45 72 80 1,227
Earnings Before Tax (7,215) (4,353) (6,644) (2,846)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,215) (4,353) (6,644) (2,846)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,215) (4,353) (6,644) (2,846)
Preferred Stock and Other Adjustments (3,175) - - (1,700)
Net Income Applicable to Common Shareholders (10,390) (4,353) (6,644) (4,546)